TransCode Therapeutics Raises $8M in Private Placement
TransCode Therapeutics ( (RNAZ) ) has shared an announcement.
Why TransCode Therapeutics (RNAZ) Stock Is Diving
TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse ...
TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4
TransCode Therapeutics (NASDAQ:RNAZ) will execute its previously announced 1-for-33 reverse stock split on Dec. 4, 2024. The company’s common stock is expected to begin trading on a split-adjusted ...
TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its ...
manilatimes3d
Sirios Resources Announces Private Placements
SIRIOS RESOURCES SIRIOS INC. (TSX-V: SOI) (the "Corporation") announces its intention to complete a non-brokered private ...
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a securities ...
labiotech6d
Seven miRNA-focused companies pioneering new therapies in 2024
Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...